We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Clinical Trial Guidance Issued for Cancer Drugs
ICH Clinical Trial Guidance Issued for Cancer Drugs
March 17, 2009
An International Conference on Harmonisation (ICH) draft guidance offers recommendations for conducting Phase I clinical trials to assess drug safety and for nonclinical studies of drugs intended for patients with advanced cancer and limited therapeutic options.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor